Management of multiple sclerosis patients after the 24th Natalizumab course: the Ty-STOP study(361 views) Clerico M, De Mercanti S, Versino E, Piazza F, Gned D, Brescia Morra V, Lanzillo R, Amato L, Quarantelli M, Ghezzi A, Bianchi A, Baroncini D, Salemi G, Realmuto S, Ferro MT, Vitetta F, Donghia M, Paolicelli D, Trojano M, Durelli L
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2013 Oct; 19(11): N/D-N/D.